Market Overview

Morning Market Losers

Share:
Related ARIA
The Medicines Company Appoints Sarissa Capital Management Exec To Its Board Of Directors
Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial
Related LRN
On Deck Capital, Spanish Broadcasting System, K12 Lead Monday's After-Hours Movers
Lost Money On K12 Shares In Late 2013? Wait Until You See What Management Kept From You...It's Not Pretty

Ariad Pharmaceuticals (NASDAQ: ARIA) plummeted 72.81% to $4.66 after the company reported that it is pausing patient enrollment in studies of Iclusig.

K12 (NYSE: LRN) dropped 36.45% to $18.17 on lower outlook. BMO Capital downgraded the stock from Outperform to Market Perform.

Pretium Resources (NYSE: PVG) dropped 22.59% to $5.24. shares have dropped 49.78% over the past 52 weeks, while the S&P 500 index has gained 15.56% in the same period.

CytRx (NASDAQ: CYTR) dropped 18.07% to $2.2450 after the company priced its underwritten public offering of 10.0 million shares of common stock at a price of $2.25 per share.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

 

Related Articles (ARIA + CYTR)

Get Benzinga's Newsletters